How Cost-of-Illness Studies Can be Made More Useful for Illicit Drug Policy Analysis

Author： Moore Timothy J.   Caulkins Jonathan P.  

Publisher： Adis International

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.5, Iss.2, 2006-01, pp. : 75-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis

By Abdullah Mohammad M. H.   Marinangeli Christopher P. F.   Jones Peter J. H.   Carlberg Jared G.  

Nutrients, Vol. 9, Iss. 7, 2017-07 ,pp. : 793-793

MDPI

Access to resources Recommend Favorite

Osteoporosis as a Candidate for Disease Management: Epidemiological and Cost-of-Illness Considerations

By Torgerson D.  

Disease Management & Health Outcomes, Vol. 3, Iss. 5, 1998-05 ,pp. : 207-214

Adis International

Access to resources Recommend Favorite

Illicit Drug Use: Can it Predict Adherence to Antiretroviral Therapy?

By Martini Michela   Recchia Elena   Nasta Paola   Castanotto Daniela   Chiaffarino Francesca   Parazzini Fabio   Agnoletto Vittorio  

European Journal of Epidemiology, Vol. 19, Iss. 6, 2004-06 ,pp. : 585-587

Springer Publishing Company

Access to resources Recommend Favorite

Assessing the Cost of Illness of Emphysema

By Guest J.F.  

Disease Management & Health Outcomes, Vol. 3, Iss. 2, 1998-02 ,pp. : 81-88

Adis International

Access to resources Recommend Favorite

A cost-effectiveness analysis of cervical cancer screening: health policy implications

By Gyrd-Hansen D.   Holund B.   Andersen P.  

Health Policy, Vol. 34, Iss. 1, 1995-10 ,pp. : 35-51

Elsevier

Access to resources Recommend Favorite